Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Stillbirth and Infant Mortality



: Stephansson O, Kieler H, Haglund B, Artama M, Engeland A, Furu K, Gissler M, Norgaard M, Nielsen RB, Zoega H, Valdimarsdottir U

Publisher: AMER MEDICAL ASSOC

: 2013

: JAMA: Journal of the American Medical Association

: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

: JAMA-J AM MED ASSOC

: 309

: 1

: 48

: 54

: 7

: 0098-7484

DOI: https://doi.org/10.1001/jama.2012.153812


Conclusions and Relevance Among women with singleton births in Nordic countries, no significant association was found between use of SSRIs during pregnancy and risk of stillbirth, neonatal mortality, or postneonatal mortality. However, decisions about use of SSRIs during pregnancy must take into account other perinatal outcomes and the risks associated with maternal mental illness.



Last updated on 2024-26-11 at 23:23